Nuvectis Pharma (NVCT) Prepaid Assets (2021 - 2026)
Nuvectis Pharma (NVCT) posted Prepaid Assets of $268000.0 for Q1 2026, up 257.33% sequentially from $75000.0 in Q4 2025, and down 5.63% YoY from $284000.0 in Q1 2025.
Nuvectis Pharma (NVCT) Prepaid Assets (2021 - 2026) Analysis & Trends
Nuvectis Pharma has reported Prepaid Assets for 6 years, with the latest figure at $268000.0 in Q1 2026.
- Quarterly Prepaid Assets fell 5.63% year-over-year to $268000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $268000.0 (down 5.63% YoY) and the FY2025 annual result came in at $75000.0, up 1.35% from the prior year.
- Prepaid Assets improved to $268000.0 in Q1 2026 per NVCT's latest filing, from $75000.0 in the prior quarter.
- Over five years, Prepaid Assets peaked at $1.2 million in Q3 2022 and troughed at $59000.0 in Q4 2023.
- A 5-year average of $364823.5 and a median of $250000.0 in 2024 frame the typical range for Prepaid Assets.
- The sharpest annual moves came in 2022 and 2023: Prepaid Assets jumped 352.75% in 2022, then tumbled 85.68% in 2023.
- Over 5 years, Prepaid Assets stood at $412000.0 in 2022, then sank by 85.68% to $59000.0 in 2023, then gained by 25.42% to $74000.0 in 2024, then increased by 1.35% to $75000.0 in 2025, then soared by 257.33% to $268000.0 in 2026.
- According to Business Quant data, Prepaid Assets over the past three periods registered $268000.0, $75000.0, and $145000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Nuvectis Pharma | 506.13 Mn | 506.13 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 216,000.00 |
| Mar 31, 2026 | 268,000.00 |
| Dec 31, 2025 | 75,000.00 |
| Sep 30, 2025 | 145,000.00 |
| Jun 30, 2025 | 214,000.00 |
| Mar 31, 2025 | 284,000.00 |
| Dec 31, 2024 | 74,000.00 |
| Sep 30, 2024 | 138,000.00 |
| Jun 30, 2024 | 182,000.00 |
| Mar 31, 2024 | 250,000.00 |
| Dec 31, 2023 | 59,000.00 |
| Sep 30, 2023 | 203,000.00 |
| Jun 30, 2023 | 341,000.00 |
| Mar 31, 2023 | 740,000.00 |
| Dec 31, 2022 | 412,000.00 |
| Sep 30, 2022 | 1.23 Mn |
| Jun 30, 2022 | 666,000.00 |
| Mar 31, 2022 | 925,000.00 |
| Dec 31, 2021 | 91,000.00 |